982 related articles for article (PubMed ID: 37217462)
1. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
2. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
Zhang J; Huang L; Ge G; Hu K
Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
[TBL] [Abstract][Full Text] [Related]
3. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
Loo Yau H; Ettayebi I; De Carvalho DD
Trends Cell Biol; 2019 Jan; 29(1):31-43. PubMed ID: 30153961
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
Niu Y; Chen J; Qiao Y
Front Immunol; 2022; 13():836223. PubMed ID: 35140725
[TBL] [Abstract][Full Text] [Related]
5. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Cao J; Yan Q
Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
Pan X; Zheng L
Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
[TBL] [Abstract][Full Text] [Related]
7. Targeting the epigenetic regulation of antitumour immunity.
Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine.
Hui L; Ziyue Z; Chao L; Bin Y; Aoyu L; Haijing W
Eur J Immunol; 2023 Apr; 53(4):e2048980. PubMed ID: 36647268
[TBL] [Abstract][Full Text] [Related]
9. Targeting the RNA m
Li X; Ma S; Deng Y; Yi P; Yu J
Mol Cancer; 2022 Mar; 21(1):76. PubMed ID: 35296338
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment.
Zhou L; Yu CW
Pharmacol Res; 2024 Jun; 204():107205. PubMed ID: 38719195
[TBL] [Abstract][Full Text] [Related]
12. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
Luo H; Shan J; Zhang H; Song G; Li Q; Xu CX
Semin Cancer Biol; 2022 Nov; 86(Pt 3):960-970. PubMed ID: 35189321
[TBL] [Abstract][Full Text] [Related]
13. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
14. Targeting the chromatin structural changes of antitumor immunity.
Li NN; Lun DX; Gong N; Meng G; Du XY; Wang H; Bao X; Li XY; Song JW; Hu K; Li L; Li SY; Liu W; Zhu W; Zhang Y; Li J; Yao T; Mou L; Han X; Hao F; Hu Y; Liu L; Zhu H; Wu Y; Liu B
J Pharm Anal; 2024 Apr; 14(4):100905. PubMed ID: 38665224
[TBL] [Abstract][Full Text] [Related]
15. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
Saleh R; Toor SM; Sasidharan Nair V; Elkord E
Front Immunol; 2020; 11():1469. PubMed ID: 32760400
[TBL] [Abstract][Full Text] [Related]
16. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications.
Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q
Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications.
Yin J; Gu T; Chaudhry N; Davidson NE; Huang Y
Front Immunol; 2023; 14():1325615. PubMed ID: 38268926
[TBL] [Abstract][Full Text] [Related]
19. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
[TBL] [Abstract][Full Text] [Related]
20. Leveraging epigenetics to enhance the efficacy of immunotherapy.
Licht JD; Bennett RL
Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
